Literature DB >> 10744663

Up-regulation of glucosylceramide synthesis upon stimulation of axonal growth by basic fibroblast growth factor. Evidence for post-translational modification of glucosylceramide synthase.

S A Boldin1, A H Futerman.   

Abstract

We have previously shown that ongoing glucosylceramide (GlcCer) synthesis is required for basic fibroblast growth factor (bFGF) and laminin to stimulate axonal growth in cultured hippocampal neurons (Boldin, S., and Futerman, A. H. (1997) J. Neurochem. 68, 882-885). We now demonstrate that stimulation of axonal growth by bFGF leads to an increase in the rate of GlcCer synthesis. Within minutes of incubation with bFGF, a significant increase in the rate of metabolism of [(14)C]hexanoyl ceramide to [(14)C]hexanoyl GlcCer is detected, but there are no changes in the rate of [(14)C]hexanoyl sphingomyelin synthesis. In vitro analysis of GlcCer synthase activity revealed an approximately 2-fold increase in the rate of [(14)C]hexanoyl GlcCer synthesis upon incubation with either bFGF or laminin; other growth factors, which did not effect the rate of axon growth, had no effect on the rate of [(14)C]hexanoyl GlcCer synthesis. The increased rate of [(14)C]hexanoyl GlcCer synthesis was not affected by preincubation with either cycloheximide or actinomycin, and no elevation of GlcCer synthase mRNA levels was detected, suggesting that GlcCer synthase is up-regulated by a post-translational mechanism. The relevance of these results for understanding the regulation of axonal growth is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744663     DOI: 10.1074/jbc.275.14.9905

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases.

Authors:  Oshrit Ben-David; Anthony H Futerman
Journal:  Neuromolecular Med       Date:  2010-05-26       Impact factor: 3.843

2.  Utilization of ganglioside-degrading Paenibacillus sp. strain TS12 for production of glucosylceramide.

Authors:  Tomomi Sumida; Noriyuki Sueyoshi; Makoto Ito
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

Review 3.  Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

Authors:  Alessandro Prinetti; Simona Prioni; Elena Chiricozzi; Edward H Schuchman; Vanna Chigorno; Sandro Sonnino
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

4.  Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2.

Authors:  Marco Rusnati; Chiara Urbinati; Elena Tanghetti; Patrizia Dell'Era; Hugues Lortat-Jacob; Marco Presta
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

Review 5.  The role of sphingolipids in neuronal development: lessons from models of sphingolipid storage diseases.

Authors:  Rosaria Buccoliero; Jacques Bodennec; Anthony H Futerman
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 6.  Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.

Authors:  Marco Piccinini; Federica Scandroglio; Simona Prioni; Barbara Buccinnà; Nicoletta Loberto; Massimo Aureli; Vanna Chigorno; Elisa Lupino; Giovanni DeMarco; Annarosa Lomartire; Maria Teresa Rinaudo; Sandro Sonnino; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.590

7.  Polarized membrane traffic and cell polarity development is dependent on dihydroceramide synthase-regulated sphinganine turnover.

Authors:  Sven C D Van IJzendoorn; Johanna M Van Der Wouden; Gerhard Liebisch; Gerd Schmitz; Dick Hoekstra
Journal:  Mol Biol Cell       Date:  2004-06-30       Impact factor: 4.138

Review 8.  Regulating survival and development in the retina: key roles for simple sphingolipids.

Authors:  Nora P Rotstein; Gisela E Miranda; Carolina E Abrahan; O Lorena German
Journal:  J Lipid Res       Date:  2010-01-25       Impact factor: 5.922

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.